Literature DB >> 17318303

Comparison of cognitive functions between people with silent and wild-type butyrylcholinesterase.

I Manoharan1, A Kuznetsova, J D Fisk, R Boopathy, O Lockridge, S Darvesh.   

Abstract

In the human brain, butyrylcholinesterase (BuChE) is expressed in neurons and glia. For example, many nuclei in the human thalamus, with projections to the cerebral cortex, contain a large number of neurons with intense BuChE activity. Thalamocortical projections subserve a variety of cognitive functions. Due to genetic mutations, there are individuals who do not have detectable BuChE activity (silent BuChE). While the prevalence of silent BuChE is only 1:100,000 in European and American populations, it is 1:24 in the Vysya community in Coimbatore, India. To examine whether there are differences in cognitive functions between individuals with silent BuChE and those expressing normal BuChE (wild-type), twelve healthy individuals with silent BuChE and thirteen healthy individuals with wild-type BuChE, all from the Vysya community in Coimbatore, were tested for cognitive function using the Automated Neuropsychological Assessment Metrics test battery. The silent BuChE group was slightly faster on simple reaction tasks, but slower on a visual perceptual matching task. Furthermore, discriminant function analyses correctly classified 11/12 silent and 8/13 wild-type BuChE subjects (76% correct classification overall) based on BuChE status. Different profiles of cognitive test performance between individuals with silent and wild-type BuChE were observed. These observations suggest a function for BuChE in cognition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318303     DOI: 10.1007/s00702-007-0631-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.850


  45 in total

1.  Factor analysis of computerized and traditional tests used in mild brain injury research.

Authors:  J Bleiberg; R L Kane; D L Reeves; W S Garmoe; E Halpern
Journal:  Clin Neuropsychol       Date:  2000-08       Impact factor: 3.535

2.  Repeated measures of cognitive processing efficiency in adolescent athletes: implications for monitoring recovery from concussion.

Authors:  J C Daniel; M H Olesniewicz; D L Reeves; D Tam; J Bleiberg; R Thatcher; A Salazar
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  1999-07

3.  Distribution of cholinesterase activity in the human cerebral cortex.

Authors:  S OKINAKA; M YOSHIKAWA; M UONO; T MURO; T MOZAI; A IGATA; H TANABE; S UEDA; M TOMONAGA
Journal:  Am J Phys Med       Date:  1961-08

4.  Refinement of the localization of human butyrylcholinesterase to chromosome 3q26.1-q26.2 using a PCR-derived probe.

Authors:  G Gaughan; H Park; J Priddle; I Craig; S Craig
Journal:  Genomics       Date:  1991-10       Impact factor: 5.736

Review 5.  The cholinesterases: from genes to proteins.

Authors:  P Taylor; Z Radić
Journal:  Annu Rev Pharmacol Toxicol       Date:  1994       Impact factor: 13.820

6.  High-speed scanning in human memory.

Authors:  S Sternberg
Journal:  Science       Date:  1966-08-05       Impact factor: 47.728

7.  Butyrylcholinesterase in the life cycle of amyloid plaques.

Authors:  A L Guillozet; J F Smiley; D C Mash; M M Mesulam
Journal:  Ann Neurol       Date:  1997-12       Impact factor: 10.422

8.  Regulation of attention and response to therapy in dementia by butyrylcholinesterase.

Authors:  Kirsty K O'Brien; Brian K Saxby; Clive G Ballard; Jan Grace; Frances Harrington; Gary A Ford; John T O'Brien; Alan G Swan; Andrew F Fairbairn; Keith Wesnes; Teodoro del Ser; James A Edwardson; Christopher M Morris; Ian G McKeith
Journal:  Pharmacogenetics       Date:  2003-04

9.  Validating a computerized neuropsychological test battery for mixed ethnic lupus patients.

Authors:  S L Holliday; M G Navarrete; D Hermosillo-Romo; C R Valdez; A R Saklad; A Escalante; R L Brey
Journal:  Lupus       Date:  2003       Impact factor: 2.911

10.  The cloned butyrylcholinesterase (BCHE) gene maps to a single chromosome site, 3q26.

Authors:  P W Allderdice; H A Gardner; D Galutira; O Lockridge; B N LaDu; P J McAlpine
Journal:  Genomics       Date:  1991-10       Impact factor: 5.736

View more
  5 in total

1.  An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestry.

Authors:  J L Meyers; J Zhang; J C Wang; J Su; S I Kuo; M Kapoor; L Wetherill; S Bertelsen; D Lai; J E Salvatore; C Kamarajan; D Chorlian; A Agrawal; L Almasy; L Bauer; K K Bucholz; G Chan; V Hesselbrock; L Koganti; J Kramer; S Kuperman; N Manz; A Pandey; M Seay; D Scott; R E Taylor; D M Dick; H J Edenberg; A Goate; T Foroud; B Porjesz
Journal:  Mol Psychiatry       Date:  2017-01-10       Impact factor: 15.992

2.  A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.

Authors:  Agneta Nordberg; Clive Ballard; Roger Bullock; Taher Darreh-Shori; Monique Somogyi
Journal:  Prim Care Companion CNS Disord       Date:  2013-03-07

3.  Altered levels of acetylcholinesterase in Alzheimer plasma.

Authors:  María-Salud García-Ayllón; Iolanda Riba-Llena; Carol Serra-Basante; Jordi Alom; Rathnam Boopathy; Javier Sáez-Valero
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

4.  New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter.

Authors:  Joanna Jońca; Monika Żuk; Bartosz Wasąg; Anna Janaszak-Jasiecka; Krzysztof Lewandowski; Bartosz Wielgomas; Krzysztof Waleron; Jacek Jasiecki
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

5.  Haplotype-based association analysis of general cognitive ability in Generation Scotland, the English Longitudinal Study of Ageing, and UK Biobank.

Authors:  David M Howard; Mark J Adams; Toni-Kim Clarke; Eleanor M Wigmore; Yanni Zeng; Saskia P Hagenaars; Donald M Lyall; Pippa A Thomson; Kathryn L Evans; David J Porteous; Reka Nagy; Caroline Hayward; Chris S Haley; Blair H Smith; Alison D Murray; G David Batty; Ian J Deary; Andrew M McIntosh
Journal:  Wellcome Open Res       Date:  2017-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.